Stock Code: 002365 Stock Abbreviation: Yong'an Pharmaceutical Announcement No.: 2026-14
Qianjiang Yong'an Pharmaceutical Co., Ltd. Announcement on Obtaining Invention Patent Certificates
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false records, misleading statements, or significant omissions.
Recently, Qianjiang Yong'an Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") received an invention patent certificate issued by the State Intellectual Property Office, the details of which are as follows:
Invention Name: A method for the simultaneous preparation of taurine, methyl taurine salts, and methyl taurine Inventors: Chen Yong; Fang Xinquan; Li Shaobo; Zhou Wei; Liu Feng; Li Xiang; Zhou Wei Patent Number: ZL 2023 1 0990015. 6 Patentee: Qianjiang Yong'an Pharmaceutical Co., Ltd. Address: No. 2 Guangze Avenue, Qianjiang Economic Development Zone, Qianjiang City, Hubei Province, 433100 Patent Application Date: August 7, 2023 Authorization Announcement Date: March 20, 2026 Authorization Announcement Number: CN 117126082 B Patent Term: 20 years from the application date
This invention patent relates to a method for producing taurine, methyl taurine salts, and methyl taurine using ethylene oxide. The final product, taurine, is mainly used in the food and beverage, pharmaceutical, and feed industries; methyl taurine salts are mainly used in the daily chemical industry; and methyl taurine is mainly used as an intermediate in fine chemicals.